191 related articles for article (PubMed ID: 24932487)
1. MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract.
Link A; Balaguer F; Nagasaka T; Boland CR; Goel A
PLoS One; 2014; 9(6):e100036. PubMed ID: 24932487
[TBL] [Abstract][Full Text] [Related]
2. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
3. Multiple Signatures of the JC Polyomavirus in Paired Normal and Altered Colorectal Mucosa Indicate a Link with Human Colorectal Cancer, but Not with Cancer Progression.
Uleri E; Piu C; Caocci M; Ibba G; Sanges F; Pira G; Murgia L; Barmina M; Giannecchini S; Porcu A; Serra C; Scanu AM; De Miglio MR; Dolei A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783512
[TBL] [Abstract][Full Text] [Related]
4. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers.
Goel A; Li MS; Nagasaka T; Shin SK; Fuerst F; Ricciardiello L; Wasserman L; Boland CR
Gastroenterology; 2006 Jun; 130(7):1950-61. PubMed ID: 16762618
[TBL] [Abstract][Full Text] [Related]
5. Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine.
Pietilä T; Nummi M; Auvinen P; Mannonen L; Auvinen E
J Clin Virol; 2015 Apr; 65():1-5. PubMed ID: 25766978
[TBL] [Abstract][Full Text] [Related]
6. JC virus mediates invasion and migration in colorectal metastasis.
Link A; Shin SK; Nagasaka T; Balaguer F; Koi M; Jung B; Boland CR; Goel A
PLoS One; 2009 Dec; 4(12):e8146. PubMed ID: 19997600
[TBL] [Abstract][Full Text] [Related]
7. Human JC polyomavirus in normal colorectal mucosa, hyperplastic polyps, sporadic adenomas, and adenocarcinomas in Portugal.
Coelho TR; Gaspar R; Figueiredo P; Mendonça C; Lazo PA; Almeida L
J Med Virol; 2013 Dec; 85(12):2119-27. PubMed ID: 24009184
[TBL] [Abstract][Full Text] [Related]
8. Patients with sporadic colorectal cancer or advanced adenomatous polyp have elevated anti-JC virus antibody titer in comparison with healthy controls: a cross-sectional study.
Niv Y; Vilkin A; Levi Z
J Clin Gastroenterol; 2010 Aug; 44(7):489-94. PubMed ID: 20421810
[TBL] [Abstract][Full Text] [Related]
9. COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
Agostini S; Mancuso R; Costa AS; Guerini FR; Clerici M
Mol Biol Rep; 2020 Nov; 47(11):9201-9205. PubMed ID: 33085050
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of JC virus in Chinese patients with colorectal cancer.
Mou X; Chen L; Liu F; Lin J; Diao P; Wang H; Li Y; Lin J; Teng L; Xiang C
PLoS One; 2012; 7(5):e35900. PubMed ID: 22606241
[TBL] [Abstract][Full Text] [Related]
11. Immune response to JC virus T antigen in patients with and without colorectal neoplasia.
Butcher LD; Garcia M; Arnold M; Ueno H; Goel A; Boland CR
Gut Microbes; 2014 Jul; 5(4):468-75. PubMed ID: 25007286
[TBL] [Abstract][Full Text] [Related]
12. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
[TBL] [Abstract][Full Text] [Related]
13. Detection of a new JCV strain of genotype A in a subpopulation of colorectal adenocarcinomas in Tunisia.
Toumi W; Ripalti A; Ricciardiello L; Cherif A; Gargouri D; Bouhafa A; Kharrat J; Jarboui S; Benrhouma H; Zili M; Khelifa R
New Microbiol; 2017 Apr; 40(2):99-106. PubMed ID: 28255604
[TBL] [Abstract][Full Text] [Related]
14. Viral miRNAs in plasma and urine divulge JC polyomavirus infection.
Lagatie O; Van Loy T; Tritsmans L; Stuyver LJ
Virol J; 2014 Sep; 11():158. PubMed ID: 25178457
[TBL] [Abstract][Full Text] [Related]
15. Assessment and biological significance of JC polyomavirus in colorectal cancer in Tunisia.
Ksiaa F; Allous A; Ziadi S; Mokni M; Trimeche M
J BUON; 2015; 20(3):762-9. PubMed ID: 26214628
[TBL] [Abstract][Full Text] [Related]
16. Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.
Takahashi K; Sekizuka T; Fukumoto H; Nakamichi K; Suzuki T; Sato Y; Hasegawa H; Kuroda M; Katano H
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795410
[TBL] [Abstract][Full Text] [Related]
17. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma.
Del Valle L; White MK; Enam S; Piña Oviedo S; Bromer MQ; Thomas RM; Parkman HP; Khalili K
Cancer; 2005 Feb; 103(3):516-27. PubMed ID: 15630684
[TBL] [Abstract][Full Text] [Related]
18. JC Polyomavirus T-antigen protein expression and the risk of colorectal cancer: Systematic review and meta-analysis of case-control studies.
Kimla LJ; Clark TG; Banerjee S; Campino S
PLoS One; 2023; 18(3):e0283642. PubMed ID: 37000859
[TBL] [Abstract][Full Text] [Related]
19. JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.
Basnyat P; Virtanen E; Elovaara I; Hagman S; Auvinen E
J Neurovirol; 2017 Oct; 23(5):734-741. PubMed ID: 28831768
[TBL] [Abstract][Full Text] [Related]
20. JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients.
Agostini S; Mancuso R; Costa AS; Caputo D; Clerici M
Viruses; 2021 Mar; 13(3):. PubMed ID: 33809082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]